Anna Pilleri
Overview
Explore the profile of Anna Pilleri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
27
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Luca F, Oliva F, Abrignani M, Di Fusco S, Gori M, Giubilato S, et al.
J Clin Med
. 2024 Apr;
13(5).
PMID: 38592244
Heart failure with preserved ejection fraction (HFpEF) is characterized by a notable heterogeneity in both phenotypic and pathophysiological features, with a growing incidence due to the increase in median age...
2.
Iorio A, Luca F, Pozzi A, Rao C, Chimenti C, Di Fusco S, et al.
Diagnostics (Basel)
. 2024 Jan;
14(2).
PMID: 38248084
Anderson-Fabry disease (AFD) is a lysosome storage disorder resulting from an X-linked inheritance of a mutation in the galactosidase A (GLA) gene encoding for the enzyme alpha-galactosidase A (α-GAL A)....
3.
Giubilato S, Luca F, Abrignani M, Gatto L, Rao C, Ingianni N, et al.
J Clin Med
. 2023 Sep;
12(18).
PMID: 37762932
Chronic coronary syndrome (CCS), which encompasses a broad spectrum of clinical presentations of coronary artery disease (CAD), is the leading cause of morbidity and mortality worldwide. Recent guidelines for the...
4.
Appropriateness of Dyslipidemia Management Strategies in Post-Acute Coronary Syndrome: A 2023 Update
Luca F, Oliva F, Rao C, Abrignani M, Amico A, Di Fusco S, et al.
Metabolites
. 2023 Aug;
13(8).
PMID: 37623860
It has been consistently demonstrated that circulating lipids and particularly low-density lipoprotein cholesterol (LDL-C) play a significant role in the development of coronary artery disease (CAD). Several trials have been...
5.
Luca F, Colivicchi F, Oliva F, Abrignani M, Caretta G, Di Fusco S, et al.
Front Cardiovasc Med
. 2023 Jun;
10:1061618.
PMID: 37304967
Intracranial hemorrhage (ICH) is considered a potentially severe complication of oral anticoagulants (OACs) and antiplatelet therapy (APT). Patients with atrial fibrillation (AF) who survived ICH present both an increased ischemic...
6.
Giubilato S, Luca F, Pozzi A, Caretta G, Cornara S, Pilleri A, et al.
J Clin Med
. 2022 Jul;
11(14).
PMID: 35887851
The combination of oral anticoagulants (OAC) and dual antiplatelet therapy (DAPT) is the mainstay for the treatment of patients with atrial fibrillation (AF) presenting with acute coronary syndrome (ACS) and/or...